Zentalis Pharmaceuticals Llc (ZNTL) earnings · $257.7M cap
These earnings events as JSON? API free 100/dayZentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
This ZNTL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ZNTL revenue for 2025-12-31 was $0. Net income was -$137.1M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. ZNTL currently screens at market cap $257.7M.
When the next ZNTL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 100.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ZNTL research stays on the stock page; the tape stays on the quote page.
ZNTL earnings FAQ
What is ZNTL's latest net income?
Latest cached Zentalis Pharmaceuticals Llc (ZNTL) net income was -$137.1M. Statements: https://lician.com/financials/zntl
What is ZNTL's latest diluted EPS?
Latest cached Zentalis Pharmaceuticals Llc (ZNTL) diluted EPS for Dec 31, 2025 was -$1.91.
What period does the latest ZNTL earnings print cover?
The latest cached Zentalis Pharmaceuticals Llc (ZNTL) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are ZNTL earnings listed?
Cached earnings facts for Zentalis Pharmaceuticals Llc (ZNTL) are listed at https://lician.com/earnings/zntl. Statements: https://lician.com/financials/zntl
Not investment advice.